TVRD Stock Analysis: Buy, Sell, or Hold?
TVRD - Tvardi Therapeutics, Inc. Common Stock
$3.10
-0.21 (-6.34%)
▼
5d:
+0.0%
30d:
+14.39%
90d:
+1.97%
BUY
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
28d
Get Alerted When TVRD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
13 traders called TVRD this week
81% bullish • 3 bearish
81% bullish • 3 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TVRD shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TVRD shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TVRD is currently trading at $3.10, which is considered slightly high relative to its 30-day fair value range of $2.00 to $3.37.
Technical Outlook: Technically, TVRD is in a downtrend. Immediate support is located at $2.75, while resistance sits at $3.57. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: TVRD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.75 (+214.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TVRD is in a downtrend. Immediate support is located at $2.75, while resistance sits at $3.57. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: TVRD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.75 (+214.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.00 -
$3.37
Company Quality Score
60/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
68.4%
All Signals
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-6.3%)
- BULLISH: Trading 214.5% below Wall St target ($9.75)
Trading Range Analysis
30-Day Trading Range
$2.00 -
$3.37
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.75
Resistance Level
$3.57
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.14
Wall Street Target
$9.75
(+214.5%)
Share & Embed Analysis
Last updated: July 15, 2026 1:59 AM ET
Data refreshes hourly during market hours. Next update: 2:59 AM
Data refreshes hourly during market hours. Next update: 2:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVRD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 51 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |